Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.

Zdenek CN, Hay C, Arbuckle K, Jackson TNW, Bos MHA, Op den Brouw B, Debono J, Allen L, Dunstan N, Morley T, Herrera M, Gutiérrez JM, Williams DJ, Fry BG.

Toxicol In Vitro. 2019 Aug;58:97-109. doi: 10.1016/j.tiv.2019.03.031. Epub 2019 Mar 22.

PMID:
30910521
2.

Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.

Zdenek CN, den Brouw BO, Dashevsky D, Gloria A, Youngman NJ, Watson E, Green P, Hay C, Dunstan N, Allen L, Fry BG.

Toxicol Lett. 2019 Nov;316:171-182. doi: 10.1016/j.toxlet.2019.08.014. Epub 2019 Aug 20.

PMID:
31442586
3.

Mud in the blood: Novel potent anticoagulant coagulotoxicity in the venoms of the Australian elapid snake genus Denisonia (mud adders) and relative antivenom efficacy.

Youngman NJ, Zdenek CN, Dobson JS, Bittenbinder MA, Gillett A, Hamilton B, Dunstan N, Allen L, Veary A, Veary E, Fry BG.

Toxicol Lett. 2019 Mar 1;302:1-6. doi: 10.1016/j.toxlet.2018.11.015. Epub 2018 Nov 28.

PMID:
30502385
4.

Antivenomic characterization of two antivenoms against the venom of the taipan, Oxyuranus scutellatus, from Papua New Guinea and Australia.

Herrera M, Paiva OK, Pagotto AH, Segura A, Serrano SM, Vargas M, Villalta M, Jensen SD, León G, Williams DJ, Gutiérrez JM.

Am J Trop Med Hyg. 2014 Nov;91(5):887-94. doi: 10.4269/ajtmh.14-0333. Epub 2014 Aug 25.

6.

Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.

Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz LF.

Toxicon. 2010 Aug 1;56(1):75-85. doi: 10.1016/j.toxicon.2010.03.013. Epub 2010 Mar 23.

PMID:
20338189
7.

Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.

Isbister GK, O'Leary MA, Hagan J, Nichols K, Jacoby T, Davern K, Hodgson WC, Schneider JJ.

Vaccine. 2010 Jan 8;28(3):798-802. doi: 10.1016/j.vaccine.2009.10.055. Epub 2009 Oct 29.

PMID:
19879227
8.

Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).

Johnston CI, Ryan NM, O'Leary MA, Brown SG, Isbister GK.

Clin Toxicol (Phila). 2017 Feb;55(2):115-122. doi: 10.1080/15563650.2016.1250903. Epub 2016 Nov 30.

PMID:
27903075
9.

Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.

Isbister GK, O'Leary MA, Schneider JJ, Brown SG, Currie BJ; ASP Investigators.

Toxicon. 2007 Jan;49(1):57-67. Epub 2006 Sep 17.

PMID:
17055016
10.

Neutralisation of the clotting activity of Australian snake venoms by snake plasma.

Smith A, Marshall LR, Mirtschin PJ, Jelinek GA.

Toxicon. 2000 Dec;38(12):1855-8.

PMID:
10858522
11.

Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.

Vargas M, Segura A, Herrera M, Villalta M, Estrada R, Cerdas M, Paiva O, Matainaho T, Jensen SD, Winkel KD, León G, Gutiérrez JM, Williams DJ.

PLoS Negl Trop Dis. 2011 May;5(5):e1144. doi: 10.1371/journal.pntd.0001144. Epub 2011 May 17.

12.

An examination of cardiovascular collapse induced by eastern brown snake (Pseudonaja textilis) venom.

Chaisakul J, Isbister GK, Kuruppu S, Konstantakopoulos N, Hodgson WC.

Toxicol Lett. 2013 Aug 29;221(3):205-11. doi: 10.1016/j.toxlet.2013.06.235. Epub 2013 Jul 2.

PMID:
23830990
15.

Catch a tiger snake by its tail: Differential toxicity, co-factor dependence and antivenom efficacy in a procoagulant clade of Australian venomous snakes.

Lister C, Arbuckle K, Jackson TNW, Debono J, Zdenek CN, Dashevsky D, Dunstan N, Allen L, Hay C, Bush B, Gillett A, Fry BG.

Comp Biochem Physiol C Toxicol Pharmacol. 2017 Nov;202:39-54. doi: 10.1016/j.cbpc.2017.07.005. Epub 2017 Jul 27.

PMID:
28757215
16.

Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).

Isbister GK, White J, Currie BJ, O'Leary MA, Brown SG; ASP Investigators.

Toxicon. 2011 Dec 1;58(8):634-40. doi: 10.1016/j.toxicon.2011.09.013. Epub 2011 Sep 28.

PMID:
21967812
17.

Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming--Australian snakebite project (ASP-14).

Allen GE, Brown SG, Buckley NA, O'Leary MA, Page CB, Currie BJ, White J, Isbister GK; ASP Investigators.

PLoS One. 2012;7(12):e53188. doi: 10.1371/journal.pone.0053188. Epub 2012 Dec 28.

18.

Comparative studies of the venom of a new Taipan species, Oxyuranus temporalis, with other members of its genus.

Barber CM, Madaras F, Turnbull RK, Morley T, Dunstan N, Allen L, Kuchel T, Mirtschin P, Hodgson WC.

Toxins (Basel). 2014 Jul 2;6(7):1979-95. doi: 10.3390/toxins6071979.

19.
20.

Neutralization of the neuromuscular inhibition of venom and taipoxin from the taipan (Oxyuranus scutellatus) by F(ab')2 and whole IgG antivenoms.

Herrera M, de Cássia de O Collaço R, Villalta M, Segura Á, Vargas M, Wright CE, Paiva OK, Matainaho T, Jensen SD, León G, Williams DJ, Rodrigues-Simioni L, Gutiérrez JM.

Toxicol Lett. 2016 Jan 22;241:175-83. doi: 10.1016/j.toxlet.2015.11.020. Epub 2015 Nov 24.

PMID:
26621539

Supplemental Content

Support Center